These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33641212)

  • 1. Estimating peptide half-life in serum from tunable, sequence-related physicochemical properties.
    Cavaco M; Valle J; Flores I; Andreu D; A R B Castanho M
    Clin Transl Sci; 2021 Jul; 14(4):1349-1358. PubMed ID: 33641212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum.
    Böttger R; Hoffmann R; Knappe D
    PLoS One; 2017; 12(6):e0178943. PubMed ID: 28575099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing of peptides with desired half-life in intestine-like environment.
    Sharma A; Singla D; Rashid M; Raghava GP
    BMC Bioinformatics; 2014 Aug; 15(1):282. PubMed ID: 25141912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid profiling of peptide stability in proteolytic environments.
    Gorris HH; Bade S; Röckendorf N; Albers E; Schmidt MA; Fránek M; Frey A
    Anal Chem; 2009 Feb; 81(4):1580-6. PubMed ID: 19159331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed α/β-Peptides as a Class of Short Amphipathic Peptide Hydrogelators with Enhanced Proteolytic Stability.
    Mangelschots J; Bibian M; Gardiner J; Waddington L; Van Wanseele Y; Van Eeckhaut A; Acevedo MM; Van Mele B; Madder A; Hoogenboom R; Ballet S
    Biomacromolecules; 2016 Feb; 17(2):437-45. PubMed ID: 26741458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro selection strategy for conferring protease resistance to ligand binding peptides.
    Eldridge B; Cooley RN; Odegrip R; McGregor DP; Fitzgerald KJ; Ullman CG
    Protein Eng Des Sel; 2009 Nov; 22(11):691-8. PubMed ID: 19755412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro metabolic stability of iodinated obestatin peptides.
    De Spiegeleer B; Van Dorpe S; Vergote V; Wynendaele E; Pauwels E; Van De Wiele C; Garcia-Solis P; Solis-Sainz JC
    Peptides; 2012 Feb; 33(2):272-8. PubMed ID: 22222609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early engineering approaches to improve peptide developability and manufacturability.
    Furman JL; Chiu M; Hunter MJ
    AAPS J; 2015 Jan; 17(1):111-20. PubMed ID: 25338742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides.
    Diao L; Meibohm B
    Clin Pharmacokinet; 2013 Oct; 52(10):855-68. PubMed ID: 23719681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide stability in drug development: a comparison of peptide reactivity in different biological media.
    Powell MF; Grey H; Gaeta F; Sette A; Colón S
    J Pharm Sci; 1992 Aug; 81(8):731-5. PubMed ID: 1403714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Analysis of Peptide-Modified Nanoparticles with Engineered Physicochemical Properties in a Mouse Model of Traumatic Brain Injury.
    Waggoner LE; Madias MI; Hurtado AA; Kwon EJ
    AAPS J; 2021 Aug; 23(5):100. PubMed ID: 34401968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proteolytic stability and cytotoxicity studies of L-aspartic acid and L-diaminopropionic acid derived beta-peptides and a mixed alpha/beta-peptide.
    Ahmed S; Kaur K
    Chem Biol Drug Des; 2009 May; 73(5):545-52. PubMed ID: 19317848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.
    Danial M; van Dulmen TH; Aleksandrowicz J; Pötgens AJ; Klok HA
    Bioconjug Chem; 2012 Aug; 23(8):1648-60. PubMed ID: 22770564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment.
    Greening DW; Kapp EA; Ji H; Speed TP; Simpson RJ
    Biochim Biophys Acta; 2013 Nov; 1834(11):2396-407. PubMed ID: 23684732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Challenge of Peptide Proteolytic Stability Studies: Scarce Data, Difficult Readability, and the Need for Harmonization.
    Cavaco M; Andreu D; Castanho MARB
    Angew Chem Int Ed Engl; 2021 Jan; 60(4):1686-1688. PubMed ID: 33200441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of peptides against proteolysis through disulfide-bridged conjugation with synthetic aromatics.
    Chen Y; Li T; Li J; Cheng S; Wang J; Verma C; Zhao Y; Wu C
    Org Biomol Chem; 2017 Feb; 15(8):1921-1929. PubMed ID: 28177025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DPP-4 Cleaves α/β-Peptide Bonds: Substrate Specificity and Half-Lives.
    Turalić A; Đeđibegović J; Hegedüs Z; Martinek TA
    Chembiochem; 2020 Jul; 21(14):2060-2066. PubMed ID: 32180303
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Marciano Y; Nayeem N; Dave D; Ulijn RV; Contel M
    ACS Biomater Sci Eng; 2023 Jun; 9(6):3379-3389. PubMed ID: 37192486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a serum stability tag for bioactive peptides.
    Jambunathan K; Galande AK
    Protein Pept Lett; 2014; 21(1):32-8. PubMed ID: 24354769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.